2020
2020
101. J. Deng, Y. Cong, X. Han, W. Wei, Y. Lu, T. Liu, W. Zhao, B. Lin, Y. Luo*, X. Zhang*, A liver-on-a-chip for hepatoprotective activity assessment, Biomicrofluidics, 14 (2020). DOI:10.1063/5.0024767
100. Q. Deng, Y. Luo, X. Zhang*, Printing perfusable and permeable vascular structure by controlled cross‐linking, Polymer Engineering & Science, (2020). DOI: 10.1002/pen.25565
99. X. Li, Q. Deng, T. Zhuang, Y. Lu, T. Liu, W. Zhao, B. Lin*, Y. Luo*, X. Zhang*, 3D bioprinted breast tumor model for structure–activity relationship study, Bio-Design and Manufacturing, 3 (2020) 361-372.
98. T. Zhuang, X. Li, Q. Deng, W. Zhao, B. Lin, Y. Luo*, X. Zhang*, A GelMA/DECM/nanoclay composite biomaterial ink for printing 3D scaffolds for primary hepatocytes cultivation, MATER LETT, 274 (2020) 128034. DOI:10.1016/j.matlet.2020.128034
97. R. Wang, Y. Liu*, Z. Han, Y. Chen, J. Wang, X. Zhang, R. Yu, X. Liang*, Integration of micro-fractionation, high-performance liquid chromatography-ultraviolet detector-charged aerosol detector-mass spectrometry analysis and cellular dynamic mass redistribution assay to accelerate alkaloid drug discovery, J CHROMATOGR A, 1616 (2020) 460779. DOI:10.1016/j.chroma.2019.460779
96. Y. Cong, X. Han, Y. Wang, Z. Chen, Y. Lu, T. Liu, Z. Wu, Y. Jin, Y. Luo*, X. Zhang*, Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review, Micromachines, 11 (2020) 381. DOI:10.3390/mi11040381
95. B. Jing, Z.A. Wang, C. Zhang, Q. Deng, J. Wei, Y. Luo, X. Zhang*, J. Li*, Y. Du*, Establishment and Application of Peristaltic Human Gut-Vessel Microsystem for Studying Host–Microbial Interaction, Frontiers in Bioengineering and Biotechnology, 8 (2020) 272. DOI:10.3389/fbioe.2020.00272
94. L. Qu, J. Wang, T. Hou, H. Zhou, Z. Wang, X. Zhang*, X. Liang*, Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays, J PHARMACOL TOX MET, 102 (2020) 106682. DOI:10.1016/j.vascn.2020.106682
93. Z. Chen, J. Deng, X. Zhang, Y. Luo*, Y. Lu, Z. Wu*, B. Lin, A novel micro-injection droplet microfluidic system for studying locomotive behavior responses to Cu2+ induced neurotoxin in individual C.elegans, Analytica Chimica Acta, 1106 (2020) 61-70. DOI:10.1016/j.aca.2020.01.050
92. H. Zhou, X. Peng, T. Hou, N. Zhao, M. Qiu, X. Zhang, X. Liang*, Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay, J ETHNOPHARMACOL, 246 (2020) 112218. DOI:10.1016/j.jep.2019.112218
2019
2019
91. L. Qu, X. Zhang*, J. Wang, H. Zhou, T. Hou, L. Wei, F. Xu, X. Liang*, Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay, Naunyn-Schmiedeberg's Archives of Pharmacology, (2019). DOI:10.1007/s00210-019-01756-6
90. R. Wang, J. Wang, Y. Liu*, X. Zhang*, X. Liang, Resonant waveguide grating based assays for colloidal aggregate detection and promiscuity characterization in natural products, RSC ADV, 9 (2019) 38055-38064. DOI:10.1039/C9RA06466D
89. J. Deng, W. Wei, Z. Chen, B. Lin*, W. Zhao, Y. Luo, X. Zhang*, Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review,Micromachines, 10 (2019) 676. DOI:10.3390/mi10100676
88. L. Wang, Y. Zhang, C. Wang, X. Zhang, Z. Wang, X. Liang, A. Alachkar*, O. Civelli*, A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia, NEUROCHEM RES, 44 (2019) 2536-2545. DOI:10.1007/s11064-019-02873-7
87. X. Guo, Z. Gao, J. Wang, Z. Guo, X. Zhang, Y. Liu, L. Wang, C. Wang*, X. Liang*, Purification of tertiary and quaternary alkaloids from Rhizoma Corydalis using reversed-phase/weak cation-exchange mixed-mode class separation combined with preparative C18 and silica based strong cation-exchange chromatography, Journal of Chromatography B, 1126-1127 (2019) 121742. DOI:10.1016/j.jchromb.2019.121742
86. J. Wang, L. Chen, L. Qu, K. Li, Y. Zhao, Z. Wang, Y. Li, X. Zhang*, Y. Jin*, X. Liang*, Isolation and bioactive evaluation of flavonoid glycosides from Lobelia chinensis Lour using two-dimensional liquid chromatography combined with label-free cell phenotypic assays, J CHROMATOGR A, 1601 (2019) 224-231. DOI:10.1016/j.chroma.2019.04.073
85. J. Deng, Z. Chen, X. Zhang*, Y. Luo, Z. Wu, Y. Lu, T. Liu, W. Zhao, B. Lin*, A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells，Biomedical Microdevices, 21 (2019) 57. DOI:10.1007/s10544-019-0414-9
84. J. Deng, X. Zhang*, Z. Chen, Y. Luo*, Y. Lu, T. Liu, Z. Wu, Y. Jin, W. Zhao, B. Lin*, A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction，Biomicrofluidics, 13 (2019) 024101. DOI:10.1063/1.5070088
83. X. You, X. Zhang, Y. Luo*, L. Liu*, W. Zhao, B. Lin，Establishment of 3D Organ Chip for Multiplexed Assessment of Type 2 Diabetes Drugs, Progress in Biochemistry and Biophysics, 46 (2019) 620-630. DOI:10.16476/j.pibb.2018.0337
82. F. Xu, H. Zhou, X. Liu, X. Zhang*, Z. Wang, T. Hou, J. Wang, L. Qu, P. Zhang, H. Piao, X. Liang*, Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products, Rsc Advances, 9 (2019) 15073-15083. DOI:10.1039/c9ra02142f
81. Y. Hu, L. Yuan, X. Zhang, H. Zhou, P. Wang, G. Li, A. Wang, Y. Cong, T. Zhang, X. Liang, W. Li*, N. Li*, Production of 1,2-Cyclohexanedicarboxylates from Diacetone Alcohol and Fumarates, ACS SUSTAIN CHEM ENG, 7 (2019) 2980-2988. DOI:10.1021/acssuschemeng.8b04310
